×
About 1,189 results

ALLMedicine™ Urologic Oncology Center

Research & Reviews  493 results

Urologic Oncology: Seminars and Original Investigations. A Twenty-Fifth Anniversary His...
https://doi.org/10.1016/j.urolonc.2021.01.024
Urologic Oncology; Droller MJ

Feb 22nd, 2021 - This narrative reviews the history of Urologic Oncology: Seminars and Original Investigations from its inception and founding through its development to reach its current status. It describes the difficulties it experienced during its initial year...

Trends in the use of administrative databases in urologic oncology: 2000-2019.
https://doi.org/10.1016/j.urolonc.2021.01.014
Urologic Oncology; Leopold Z, Dave P et. al.

Feb 8th, 2021 - Administrative databases (AD) provide investigators with nationally representative study populations to answer research questions using large sample sizes. We aimed to quantify the trends and incidence of AD use in published manuscripts in urologi...

Defining oligometastatic hormone sensitive prostate cancer and clinically significant o...
https://doi.org/10.1016/j.urolonc.2020.12.006
Urologic Oncology; Herrera-Caceres JO, Gleave A et. al.

Jan 26th, 2021 - With the current movement toward treating oligometastatic hormone sensitive prostate cancer (OMPC), we design a study with the objective of gathering opinions regarding what would be considered a clinically significant benefit from such treatments...

A history of the Society of Urologic Oncology.
https://doi.org/10.1016/j.urolonc.2020.12.018
Urologic Oncology; Lange PH, Cookson MS et. al.

Jan 17th, 2021 - This narrative of the history of the Society of Urologic Oncology (SUO) presents the story of the founding and development of this organization and the creation and establishment of its initiatives and programs. It includes a description of how "U...

Changing the Status Quo: The 100 Most-Disruptive Papers in Urology?
https://doi.org/10.1016/j.urology.2020.10.073
Urology Khusid JA, Gupta M et. al.

Jan 7th, 2021 - To identify key papers in urology using a novel bibliometric index called the disruption score. A PubMed search was conducted to identify papers published in Journal of Urology, European Urology, Urology, Urologic Oncology, Journal of Endourology,...

see more →

Guidelines  3 results

Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline
http://ascopubs.org/doi/full/10.1200/JCO.18.00606
Bekelmanm J.,et al

Sep 4th, 2018 - Purpose In April 2017, the American Urological Association, American Society for Radiation Oncology, and Society of Urologic Oncology released a joint evidence-based practice guideline on clinically localized prostate cancer. The American Society ...

Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Associat...
https://doi.org/10.1200/JOP.2017.024919
Journal of Oncology Practice; Chang SS, Bochner BH et. al.

Aug 10th, 2017 - Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary.|2017|Chang S...

Hematuria as a Marker of Occult Urinary Tract Cancer: Advice for High-Value Care From the Am...
http://annals.org/aim/fullarticle/2484287/hematuria-marker-occult-urinary-tract-cancer-advice-high-value-care?resultClick=3
Matthew Nielsen

Apr 4th, 2016 - The presence of blood in the urine, or hematuria, is a common finding in clinical practice and can sometimes be a sign of occult cancer. This article describes the clinical epidemiology of hematuria and the current state of practice and science in.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  601 results

Urologic Oncology: Seminars and Original Investigations. A Twenty-Fifth Anniversary His...
https://doi.org/10.1016/j.urolonc.2021.01.024
Urologic Oncology; Droller MJ

Feb 22nd, 2021 - This narrative reviews the history of Urologic Oncology: Seminars and Original Investigations from its inception and founding through its development to reach its current status. It describes the difficulties it experienced during its initial year...

Trends in the use of administrative databases in urologic oncology: 2000-2019.
https://doi.org/10.1016/j.urolonc.2021.01.014
Urologic Oncology; Leopold Z, Dave P et. al.

Feb 8th, 2021 - Administrative databases (AD) provide investigators with nationally representative study populations to answer research questions using large sample sizes. We aimed to quantify the trends and incidence of AD use in published manuscripts in urologi...

Defining oligometastatic hormone sensitive prostate cancer and clinically significant o...
https://doi.org/10.1016/j.urolonc.2020.12.006
Urologic Oncology; Herrera-Caceres JO, Gleave A et. al.

Jan 26th, 2021 - With the current movement toward treating oligometastatic hormone sensitive prostate cancer (OMPC), we design a study with the objective of gathering opinions regarding what would be considered a clinically significant benefit from such treatments...

A history of the Society of Urologic Oncology.
https://doi.org/10.1016/j.urolonc.2020.12.018
Urologic Oncology; Lange PH, Cookson MS et. al.

Jan 17th, 2021 - This narrative of the history of the Society of Urologic Oncology (SUO) presents the story of the founding and development of this organization and the creation and establishment of its initiatives and programs. It includes a description of how "U...

Changing the Status Quo: The 100 Most-Disruptive Papers in Urology?
https://doi.org/10.1016/j.urology.2020.10.073
Urology Khusid JA, Gupta M et. al.

Jan 7th, 2021 - To identify key papers in urology using a novel bibliometric index called the disruption score. A PubMed search was conducted to identify papers published in Journal of Urology, European Urology, Urology, Urologic Oncology, Journal of Endourology,...

see more →

News  91 results

Combined MRI and Ultrasound Prostate Biopsy: 'Paradigm Shift'
https://www.medscape.com/viewarticle/926547

Mar 9th, 2020 - Combining MRI-guided biopsy of the prostate with conventional ultrasound-guided 12-core prostate biopsy was superior to either technique alone at ruling out more aggressive cancers, and beat MRI-guided biopsy alone at detecting clinically signific...

Adjunctive surgery may be unnecessary in many testicular cancer patients
https://www.mdedge.com/hematology-oncology/article/217932/genitourinary-cancer/adjunctive-surgery-may-be-unnecessary-many?channel=39313
Susan London

Feb 26th, 2020 - SAN FRANCISCO – A large share of men with testicular cancer undergoing postchemotherapy retroperitoneal lymph node dissection (RPLND) may be having organs unnecessarily removed at the time, a retrospective analysis suggests. However, determining w.

Seminoma: Risk-adapted strategy could mean less toxic chemo
https://www.mdedge.com/fedprac/avaho/article/217695/genitourinary-cancer/seminoma-risk-adapted-strategy-could-mean-less/page/0/1?channel=53

Feb 22nd, 2020 - Study details Although 72% of patients in SEMITEP had a negative early FDG-PET result, four of them requested standard chemotherapy anyway and were analyzed in that group, Dr. Loriot noted at the symposium, which was sponsored by the American Soci.

First Results for Nanosphere Focal Therapy in Prostate Cancer
https://www.medscape.com/viewarticle/917344

Aug 27th, 2019 - When imaging of the prostate shows only one small area of cancer, "why can't you treat just that spot, instead of the whole prostate?" frustrated patients keep asking. This is what a new approach now being tested aims to do, says Ardeshir R. Rasti...

Pembrolizumab-axitinib nearly halves risk of death in RCC
https://www.mdedge.com/hematology-oncology/article/194359/renal-cell-carcinoma/pembrolizumab-axitinib-nearly-halves-risk?channel=39313
Susan London

Feb 12th, 2019 - SAN FRANCISCO – When used as first-line therapy for renal cell carcinoma (RCC), the combination of pembrolizumab and axitinib has similar safety and better efficacy than single-agent sunitinib, the current standard of care, according to findings o.

see more →